Browsed by
Tag: Federal Drug Policy

Trump Administration Confirms Active Review of Marijuana’s Drug Classification

Trump Administration Confirms Active Review of Marijuana’s Drug Classification

Trump Administration Confirms Active Review of Marijuana’s Drug Classification President Donald Trump confirmed on Monday that his administration is actively exploring the reclassification of marijuana, potentially moving it to a less dangerous drug category. Speaking from the White House, Trump indicated a decision on the “very complicated subject” could be reached within the coming weeks. The consideration involves rescheduling marijuana from a Schedule I drug—currently grouped with substances like heroin and LSD—to a Schedule III drug. Schedule III drugs are…

Read More Read More

Biden Administration Moves to Reclassify Cannabis, Easing Federal Restrictions

Biden Administration Moves to Reclassify Cannabis, Easing Federal Restrictions

Biden Administration Moves to Reclassify Cannabis, Easing Federal Restrictions The Biden administration is poised to enact a monumental shift in federal drug policy, moving to reclassify cannabis from its stringent Schedule I status to the less restrictive Schedule III under the Controlled Substances Act. This historic move, the first of its kind in over 50 years, signifies a federal acknowledgment of marijuana’s potential medical benefits, paving the way for further research and significant changes for the burgeoning cannabis industry. Sources…

Read More Read More